Screening moved forward in less than two months
For this Phase 1/2 plaque psoriasis study, WCR screened 15 participants in less than two months, building early momentum for the study.
Phase 1/2 · Plaque psoriasis
Fifteen screened. Thirteen randomized.
WCR screened 15 participants in less than two months for a Phase 1/2 plaque psoriasis study. Thirteen were randomized, with one screen failure and one early withdrawal.
Explore the study storyStudy outcome
13participants randomized from 15 screened15screened in less than 2 months
13participants randomized
86.7%screened-to-randomized conversion
Inside the case
Thirteen participants reached randomization
Thirteen of the 15 screened participants were randomized, representing an 86.7% screening-to-randomization conversion. The other two participants accounted for one screen failure and one early withdrawal.
Participation started with preparation
Our team discussed study requirements before screening and maintained open communication throughout participation. This relationship-focused approach supported high compliance among active participants, alongside the study’s 13 randomizations.
The challenge. Our response.
Clear eligibility. Clear procedure expectations.
Restrictive eligibility criteria and a required biopsy made early conversations about both qualification and participation especially important.
Restrictive eligibility
The challenge
A candidate’s interest in the trial did not by itself establish that the protocol’s eligibility criteria were met.
How our team responds
We focus pre-screening on the protocol requirements and discuss the participation commitment before scheduling screening, helping candidates understand the process from the start.
A required biopsy
The challenge
The biopsy requirement was a meaningful consideration for candidates deciding whether to participate.
How our team responds
We explain the biopsy requirement before screening, make room for questions, and clarify the visit expectations. Open communication continues throughout participation so concerns can be raised with the study team.
Study outcome
15 screened in less than two months. Thirteen participants randomized.
The participant experience
Recruit with the full study experience in mind.
Before screening, our team discussed participation requirements and readiness to follow the study plan. Relationship building and open communication continued during the trial, supporting high compliance among active participants.
Set expectations before screening
We discuss the study commitment early, including what participation will require and whether candidates feel ready to meet those expectations. Pre-screening helps establish a shared understanding before the first screening visit.
Build a working relationship
Participants need a team they can talk to. We build relationships throughout the study and keep communication open so questions and practical concerns can be raised with the site.
Keep the focus on follow-through
Our participant engagement approach continues beyond randomization. We stay connected throughout participation to support retention and compliance with study requirements.
Practical participant support
Help with the journey.
Support through the study.
We provide transportation support when needed to help participants attend study visits. We also discuss scheduling concerns early and maintain open communication throughout participation, helping address the practical barriers that can make follow-through difficult.
The result
15 screened in less than two months. Thirteen participants randomized.
Phase 1/2 · Plaque psoriasis · WCR case study
Your next study
Build your next study
on a stronger start.
Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.